|
|
Volumn 13, Issue 2, 2007, Pages 78-85
|
|
New path to profits in biotech: Taking the acquisition exit
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RETURN ON INVESTMENTS;
TRADE SALES;
VENTURE CAPITALISTS;
COMMERCE;
COST BENEFIT ANALYSIS;
INVESTMENTS;
MARKETING;
SALES;
BIOTECHNOLOGY;
ARTICLE;
BIOTECHNOLOGY;
CAPITAL;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
DRUG MARKETING;
ECONOMIC ASPECT;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HEALTH CARE QUALITY;
INVESTMENT;
LICENSING;
PROFIT;
STRATEGIC PLANNING;
|
|
EID: 34447264801
PISSN: 14628732
EISSN: None
Source Type: Journal
DOI: 10.1057/palgrave.jcb.3050045 Document Type: Article |
|
Times cited : (17)
|
|
References (0)
|